Pirtobrutinib Shows Similar Efficacy to Ibrutinib in CLL

A randomized phase 3 trial focused on patients with treatment-naive or relapsed/refractory disease.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/pirtobrutinib-shows-similar-efficacy-ibrutinib-cll-2025a1000yho?src=rss

Author :

Publish date : 2025-12-09 12:26:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Pirtobrutinib Shows Similar Efficacy to Ibrutinib in CLL

Helping Patients Transition From Pediatrics to Your Practice

IL-6 Vaccine Shows Early Benefit in Knee Osteoarthritis

Related Posts

Ketamine Not a Better Anesthetic for Intubation of Critically Ill Patients

Energy Drinks Blamed for Man’s Severe High Blood Pressure, Stroke

Rare Temporary Flu Complication Can Leave Some Kids Unable to Walk

Material Hardship, ‘Catastrophic’ Income Loss Common in Families of Kids With ALL

Cheap Drug During High-Risk Surgery Reduces Blood Transfusions

‘We Must Absolutely Ignore Them’: Experts Defy CDC Panel’s Hep B Vaccine Vote

Ketamine Not a Better Anesthetic for Intubation of Critically Ill Patients

Energy Drinks Blamed for Man’s Severe High Blood Pressure, Stroke

Rare Temporary Flu Complication Can Leave Some Kids Unable to Walk

Material Hardship, ‘Catastrophic’ Income Loss Common in Families of Kids With ALL

Cheap Drug During High-Risk Surgery Reduces Blood Transfusions

‘We Must Absolutely Ignore Them’: Experts Defy CDC Panel’s Hep B Vaccine Vote

Parkinson’s and Flu Vaccines; Sleep and Life Expectancy; Positive Duchenne Data

Bispecific Trial in Myeloma Sparks Talks of ‘Functional Cure’

Categories

Archives